Needham analyst Kyle Peterson upgraded Open Lending (LPRO) to Buy from Hold with a $7 price target The firm sees signs of stabilization and ...
Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s ...
Buy LPRO near 4.64 target 5.53 stop loss @ 4.63 Details The technical summary data tells us to buy LPRO near 4.64 with an upside target of 5.53. This data also tells us to set a stop loss @ 4.63 ...
AUSTIN, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...